Broncus Tech Raises $38 Million

Broncus Technologies Inc., a Mountain View, Calif.-based developer of medical devices for emphysema and other lung diseases, has raised $38 million in Series G funding. Ares Life Sciences led the round with a $25 million investment, and was joined by return backers Abingworth, Bio*One/Singapore, Charter Ventures, HBM BioVentures, JAIC America, Menlo Ventures, Pac-Link Ventures, Saints Capital and Sightline Ventures. The company had previously raised around $73 million, and earlier this year canceled a planned IPO.

North AmericaUSBriefs